Leung, R. C., Yau, T., Kichenadasse, G., Wong, D. A., Luk, J. M., Souza, P. L. D. (2026). Phase 1, FIH study of cabotamig, a TCE CDH17 X CD3, in CDH17-expressing GI malignancies.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.3603